Financing channel feed – Endpoints News

Financing channel feed

Cowen, Longwood add $735M to biopharma's pool of money

3 years ago

Radioantibody startup led by prostate cancer experts raises $90M

3 years ago

Morphic Therapeutic follows positive data readout for UC drug with $240M public offering

3 years ago

ARTHEx nabs Series B for clinical trial of ASO in myotonic dystrophy as Vertex’s deals heat up the space

3 years ago

Durham startup raises Series A to tackle undruggable proteins, including cancer baddie Myc, with generative AI

3 years ago

Milestone Monday for Immatics’ Bristol Myers-allied cell therapy and 2seventy bio’s Novo-partnered hemophilia A work

3 years ago

'Undruggable is only at a given point in time': Prominent California scientists launch Initial Therapeutics with $75M

3 years ago

Acelyrin sets out for a 2021-sized IPO for California biotech’s PhIII drug

3 years ago

One SPAC inks biotech merger, while another linked to former Biden cancer moonshot leader will shut down

3 years ago

Foresight Diagnostics' approach for the earlier detection of cancer recurrence pulls in nearly $59M

3 years ago

Pattern Bioscience raises $28.7M Series C for faster, more efficient antibiotic resistance test

3 years ago

‘Sleeping blockbuster’: MPM leads $53M Series E for Antiva as biotech seeks second go at tackling HPV

3 years ago

Exclusive: Therini raises $36M, will target fibrin protein for Alzheimer's and diabetic macular edema

3 years ago

Evommune raises $50M to fund clinical trials in skin diseases

3 years ago

With $270M, Beam spinoff Orbital Therapeutics builds RNA medicines as it hunts for partners, more delivery tech

3 years ago

J&J's consumer health spinout Kenvue lines up a $3B+ IPO, biggest health offering since 2018

3 years ago

Ideaya goes forward with $150M offering after touting PhII cancer data

3 years ago

Pfizer-backed Vedanta Biosciences lands $106M for PhIII in C. diff, PhII in IBD

3 years ago

PharmaEssentia secures $462M+ to further growth of Besremi and its pipeline

3 years ago

Chinese biotech startup adds $315M to the bank after bringing 5 Takeda drugs to its fold

3 years ago

Abdera raises $110M to push targeted radiotherapies where they haven’t gone before

3 years ago

Legend raises $200M from private investor after conference leaks PhIII Carvykti data

3 years ago

Vaxcyte to raise $500M from stock offering for PhIII study of pneumococcal vaccine

3 years ago

Gilde Healthcare bags $657M to fuel 'holistic' search for affordable drugs, technologies

3 years ago

First page Previous page 35 36 373839 40 41 Next page Last page